Enantioselective synthesis of 1-methoxy- and 1-deoxy-2′-methyl-Δ8-tetrahydrocannabinols:: New selective ligands for the CB2 receptor

被引:13
作者
Huffman, JW [1 ]
Bushell, SM
Joshi, SN
Wiley, JL
Martin, BR
机构
[1] Clemson Univ, Howard L Hunter Lab, Clemson, SC 29634 USA
[2] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll Virgina Campus, Richmond, VA 23298 USA
关键词
cannabinoids; structure-activity relationships; cannabinoid receptors; enantioselective synthesis;
D O I
10.1016/j.bmc.2005.08.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two new series of cannabinoids were prepared and their affinities for the CB1 and CB2 receptors were determined. These series are the (2'R)- and (2'S)-1-methoxy- and 1-deoxy-3-(2'-methylalkyl)-Delta(8)-tetrahydrocannabinols, with alkyl side chains of three to seven carbon atoms. These compounds were prepared by a route that employed the enantioselective synthesis of the resorcinol precursors to the cannabinoid ring system. All of these compounds have greater affinity for the CB2 receptor than the CB1 receptor and four or them, (2'R)-1-methoxy-3-(2'-methylbutyl)-Delta(8)-THC (JWH-359), (2'S)-1-deoxy-3-(2'-methylbutyl)-Delta(8)-THC (JWH-352), (2',S)-1-deoxy-3-(2'-methylpentyl)-Delta(8)-THC (JWH-255), and (2'R)-1-deoxy-3-(2'-methylpentyl)-Delta(8)-THC (JWH-255). have good affinity (K-i = 13-47 nM) for the CB2 receptor and little affinity (K-i = 1493 to > 10,000 nM) for the CB1 receptor. In the 1-deoxy-3-(2'-methylalkyl)-Delta(8)-THC series, the 2'S-methyl compounds in general have greater affinity for the CB2 receptor than the corresponding 2'R isomers. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:247 / 262
页数:16
相关论文
共 49 条
[1]  
BAB I, 2004, 2004 S CANN INT CAN, P74
[2]   Targeting the endocannabinoid system in cancer therapy: A call for further research [J].
Bifulco, M ;
Di Marzo, V .
NATURE MEDICINE, 2002, 8 (06) :547-550
[3]   Evidence for a new G protein-coupled cannabinoid receptor in mouse brain [J].
Breivogel, CS ;
Griffin, G ;
Di Marzo, V ;
Martin, BR .
MOLECULAR PHARMACOLOGY, 2001, 60 (01) :155-163
[4]   Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor [J].
Buckley , NE ;
McCoy, KL ;
Mezey, É ;
Bonner, T ;
Zimmer, A ;
Felder, CC ;
Glass, M ;
Zimmer, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 396 (2-3) :141-149
[5]  
BUSHELL SM, UNPUB
[6]   Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors [J].
Casanova, ML ;
Blázquez, C ;
Martínez-Palacio, J ;
Villanueva, C ;
Fernández-Aceñero, MJ ;
Huffman, JW ;
Jorcano, JL ;
Guzmán, M .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (01) :43-50
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain [J].
Clayton, N ;
Marshall, FH ;
Bountra, C ;
O'Shaughnessy, CT .
PAIN, 2002, 96 (03) :253-260
[9]  
Compton DR, 1996, J PHARMACOL EXP THER, V277, P586
[10]  
COMPTON DR, 1993, J PHARMACOL EXP THER, V265, P218